Oxford Immunotec Global PLC is a biotechnology company that specializes in developing and commercializing proprietary tests for the diagnosis of various diseases. The company’s main product is the T-SPOT.TB test, which is used to diagnose tuberculosis. Oxford Immunotec Global PLC also offers tests for other diseases such as Lyme disease and Babesiosis. The company was founded in 2002 and is headquartered in Abingdon, United Kingdom. It has operations in Europe, Asia, and the Americas, and serves customers in over 50 countries worldwide. Oxford Immunotec Global PLC is committed to improving global health by providing accurate and reliable diagnostic tests that help healthcare professionals make informed decisions about patient care.
